Intellia Therapeutics Inc (NTLA) — Capital Reinvestment Ratio
Latest as of June 2020:
0.02x
Intellia Therapeutics Inc (NTLA) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($57.42 Million) in capital expenditures ($1.04 Million). See free cash flow generation of Intellia Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$57.42 Million
USD
Capital Expenditures
$1.04 Million
USD
Data as of
Jun 2020
Most recent filing
Intellia Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Intellia Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Intellia Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Intellia Therapeutics Inc from 2016 to 2016. For live market cap and broader valuation context, see how much is Intellia Therapeutics Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $36.11 Million | $6.17 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow